|
|
Volumn 2016, Issue SEP, 2016, Pages
|
|
Eluxadoline: A promising therapy that raises many questions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
DELTA OPIATE RECEPTOR;
ELUXADOLINE;
KAPPA OPIATE RECEPTOR;
MU OPIATE RECEPTOR;
PLACEBO;
RIFAXIMIN;
ABDOMINAL DISTENSION;
ABDOMINAL PAIN;
CONSTIPATION;
DIGESTIVE TRACT PARAMETERS;
DISEASE CLASSIFICATION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG SAFETY;
GASTROENTERITIS;
HUMAN;
IRRITABLE COLON;
MEDICAL LITERATURE;
NAUSEA;
OFF LABEL DRUG USE;
OUTCOME ASSESSMENT;
PANCREATITIS;
PATIENT SELECTION;
PHASE 3 CLINICAL TRIAL (TOPIC);
REVIEW;
RISK BENEFIT ANALYSIS;
ROME III CRITERIA;
STOOL CONSISTENCY;
TRAVELLER DIARRHEA;
VOMITING;
|
|
EID: 85007028343
PISSN: 2224476X
EISSN: 22244778
Source Type: Journal
DOI: 10.21037/tgh.2016.09.06 Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
